ResMed outlines 61%-63% gross margin target for FY26 while ramping up share buybacks and dividend
Source: SeekingAlpha
2025-07-31 21:39:57 ET
More on ResMed
- ResMed Inc. (RMD) Q4 2025 Earnings Call Transcript
- ResMed: A Sleeping Giant Hiding In Plain Sight
- ResMed Non-GAAP EPS of $2.55 beats by $0.07, revenue of $1.3B misses by $30M
- ResMed Q4 2025 Earnings Preview
- Seeking Alpha’s Quant Rating on ResMed
Read the full article on Seeking Alpha
For further details see:
ResMed outlines 61%–63% gross margin target for FY26 while ramping up share buybacks and dividend
Resmed Inc. Chess Depository Interest
NASDAQ: RSMDF
RSMDF Trading
0.0% G/L:
$25.67 Last:
507 Volume:
$25.67 Open:
RSMDF Latest News
RSMDF Stock Data
$40,201,411,540
146,930,660
N/A
121
N/A
Medical Equipment & Supplies
Healthcare
US
San Diego
